|
Biotricity Inc 's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 21.73% in the third quarter 2025, year on year to cumulative value of $13 million, Biotricity Inc 's revenue per employee grew on a trailing twelve months basis to $ 873,008, this marks a new company high. Within the Healthcare sector Employees of 124 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1023, from total ranking in previous quarter at 1056. Biotricity Inc has 15 employees.
What is Sales per Employee Ratio?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BTCY Revenue per Employee |
(Dec 31 2024)
III. Quarter |
(Sep 30 2024)
II. Quarter |
(Jun 30 2024)
I. Quarter |
(Mar 31 2024)
IV. Quarter |
(Dec 31 2023)
III. Quarter |
| Y / Y Revenue Change |
21.73 % |
12 % |
16.75 % |
22.29 % |
24.84 % |
| Sales per Employee (TTM) $ |
873,008 |
829,932 |
806,590 |
775,969 |
739,419 |
| BTCY's Total
Ranking |
# 1023 |
# 1056 |
# 0 |
# 0 |
# 0 |
| Seq. Revenue Change |
10.78 % |
2.03 % |
6.46 % |
1.16 % |
1.93 % |
| Revenue per Employee Statistics |
| High |
Average |
Low |
| $ 873,008 |
$ 420,192 |
$ 26,547 |
| (Dec 31 2024) |
|
(Mar 31 2019) |
Date modified: 2025-04-11T08:54:34+00:00
| Companies with similar Revenue per Employee for 12 months ending Dec 31 2024, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Dec 31 2024 | Number of Employees Dec 31 2024 | | The Beauty Health Company | 1,521,899.54 | $ 333.296 Million | 219 | | Genedx Holdings Corp | 1,511,866.34 | $ 305.397 Million | 202 | | Fortrea Holdings Inc | 1,498,000.00 | $ 2,696.400 Million | 1,800 | | Jazz Pharmaceuticals Plc | 1,453,196.43 | $ 4,068.950 Million | 2,800 | | Sarepta Therapeutics Inc | 1,447,472.60 | $ 1,901.979 Million | 1,314 | | Kiniksa Pharmaceuticals International Plc | 1,425,047.14 | $ 423.239 Million | 297 | | Bristol myers Squibb Company | 1,416,422.29 | $ 48,300.000 Million | 34,100 | | Mannkind Corporation | 1,413,386.14 | $ 285.504 Million | 202 | | Voyager Therapeutics Inc | 1,403,526.32 | $ 80.001 Million | 57 | | Amgen Inc | 1,392,666.67 | $ 33,424.000 Million | 24,000 | | Collegium Pharmaceutical inc | 1,380,842.73 | $ 465.344 Million | 337 | | Sanuwave Health Inc | 1,359,750.00 | $ 32.634 Million | 24 | | Hutchmed china Limited | 1,349,466.81 | $ 630.201 Million | 467 | | Rigel Pharmaceuticals Inc | 1,327,985.19 | $ 179.278 Million | 135 | | Biofrontera Inc | 1,317,655.91 | $ 122.542 Million | 93 | | Arvinas Inc | 1,303,960.40 | $ 263.400 Million | 202 | | Evoke Pharma Inc | 1,281,176.88 | $ 10.249 Million | 8 | | Biogen Inc | 1,278,190.22 | $ 9,675.900 Million | 7,570 | | Ufp Technologies Inc | 1,256,092.27 | $ 503.693 Million | 401 | | Eton Pharmaceuticals Inc | 1,239,064.52 | $ 38.411 Million | 31 | | Avita Medical Inc | 1,235,596.15 | $ 64.251 Million | 52 | | Iovance Biotherapeutics inc | 1,215,333.33 | $ 164.070 Million | 135 | | Sensus Healthcare Inc | 1,183,742.86 | $ 41.431 Million | 35 | | Equillium Inc | 1,174,142.86 | $ 41.095 Million | 35 | | Rhythm Pharmaceuticals inc | 1,172,306.31 | $ 130.126 Million | 111 | | Cytomx Therapeutics Inc | 1,150,858.33 | $ 138.103 Million | 120 | | International Stem Cell Corporation | 1,135,625.00 | $ 9.085 Million | 8 | | Abbvie Inc | 1,126,680.00 | $ 56,334.000 Million | 50,000 | | Procept Biorobotics Corporation | 1,109,400.99 | $ 224.099 Million | 202 | | Apellis Pharmaceuticals Inc | 1,108,321.99 | $ 781.367 Million | 705 |
|
